# David Cella

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/david-cella/

## Facts

| Field | Value |
| --- | --- |
| Citations | 152,055 |
| Field | Cancer survivorship and care |
| h-index | 186 |
| i10-index | 1,009 |
| Last Known Institution | Northwestern University |
| OpenAlex ID | https://openalex.org/A5039180386 |
| ORCID iD | 0000-0002-9881-4541 |
| Works | 1,886 |

## Researcher papers

Showing 12 of 30.

- [The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.](https://scholariq.org/papers/the-functional-assessment-of-cancer-therapy-scale-development-and-validation-of/)
- [The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008](https://scholariq.org/papers/the-patient-reported-outcomes-measurement-information-system-promis-developed/)
- [Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT Recommendations](https://scholariq.org/papers/interpreting-the-clinical-importance-of-treatment-outcomes-in-chronic-pain/)
- [The Patient-Reported Outcomes Measurement Information System (PROMIS)](https://scholariq.org/papers/the-patient-reported-outcomes-measurement-information-system-promis/)
- [Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer](https://scholariq.org/papers/paclitaxel-plus-bevacizumab-versus-paclitaxel-alone-for-metastatic-breast-cancer/)
- [Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer](https://scholariq.org/papers/efficacy-of-gefitinib-an-inhibitor-of-the-epidermal-growth-factor-receptor/)
- [Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes](https://scholariq.org/papers/recommended-methods-for-determining-responsiveness-and-minimally-important/)
- [Item Banks for Measuring Emotional Distress From the Patient-Reported Outcomes Measurement Information System (PROMIS®): Depression, Anxiety, and Anger](https://scholariq.org/papers/item-banks-for-measuring-emotional-distress-from-the-patient-reported-outcomes/)
- [Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items](https://scholariq.org/papers/development-of-physical-and-mental-health-summary-scores-from-the-patient/)
- [Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system](https://scholariq.org/papers/measuring-fatigue-and-other-anemia-related-symptoms-with-the-functional/)
- [Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma](https://scholariq.org/papers/pazopanib-versus-sunitinib-in-metastatic-renal-cell-carcinoma/)
- [Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.](https://scholariq.org/papers/reliability-and-validity-of-the-functional-assessment-of-cancer-therapy-breast/)

## Researcher topics

- [Cancer survivorship and care](https://scholariq.org/topics/cancer-survivorship-and-care/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Childhood Cancer Survivors' Quality of Life](https://scholariq.org/topics/childhood-cancer-survivors-quality-of-life/)
- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)

## Researcher university

- [Northwestern University](https://scholariq.org/institutions/northwestern-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.